「fo」の検索結果
132件：96～100件目を表示
-
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708.pdf -
. The OptiLight M22 IPL Model is the newest IPL treatment device equipped with a system specialized for the ophthalmology field. This OptiLight M22 IPL Model is indicated for improvement of symptoms o...
https://www.senju.co.jp/sites/default/files/content_news/2023-11/ENG__20231101_0.pdf -
Quality Policies | About Senju | SENJU Pharmaceutical
We will set the following "Quality Policies" and continue to be a "Good Company" by encouraging cooperation among all employees and providing high-quality products for "realiz...
https://www.senju.co.jp/english/about/quality.html -
. The OptiLight M22 IPL Model is the newest IPL treatment device equipped with a system specialized for the ophthalmology field. This OptiLight M22 IPL Model is indicated for improvement of symptoms o...
https://www.senju.co.jp/sites/default/files/content_news/2023-11/ENG__20231101.pdf -
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708_0.pdf